Related Experiment Video

Updated: Jan 9, 2026

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.6K

[Mild cognitive impairment: a prodromal phase of dementia?]

C Jonker1, H C Comijs

  • 1VU medisch centrum, EMGO Instituut, Amsterdam. c.jonker@vumc.nl

Tijdschrift Voor Gerontologie En Geriatrie
|July 24, 2007
PubMed

Insights

Mild Cognitive Impairment (MCI) is a common condition in older adults, often preceding Alzheimer disease (AD). This review clarifies MCI concepts, neuropsychiatric features, and healthcare implications of preclinical diagnoses.

Area of Science:

  • Gerontology
  • Neurology
  • Cognitive Science

Context:

  • Cognitive decline without dementia is prevalent in aging populations.
  • Numerous clinical concepts have emerged to describe age-related cognitive deficits.
  • Mild Cognitive Impairment (MCI) is the most recognized concept.

Purpose:

  • To review various clinical concepts for cognitive deficits in older persons.
  • To examine Mild Cognitive Impairment (MCI) as a prodromal phase of Alzheimer disease (AD).
  • To clarify neuropsychiatric features, predictors of dementia conversion, and healthcare consequences of preclinical diagnoses.

Summary:

  • Mild Cognitive Impairment (MCI) is frequently considered a precursor to Alzheimer disease (AD).
  • The review discusses different conceptualizations of MCI, including its neuropsychiatric manifestations.
  • Predictors for conversion to dementia and the impact of early diagnosis on healthcare are elucidated.

Impact:

  • Provides a comprehensive overview of Mild Cognitive Impairment (MCI) and its relationship to Alzheimer disease (AD).
  • Enhances understanding of neuropsychiatric features and conversion predictors in aging cognitive decline.
  • Clarifies the implications of preclinical diagnoses for healthcare planning and patient management.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.7K

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
486
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
745
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
512
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Amnesia01:13

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
414